[Flow cytometric analysis of mesothelial cells in peritoneal dialysis effluent]

Eiichiro Kanda1, Kenji Takai, Yoshitaka Maeda

  • 1Nephrology Section, Department of Internal Medicine, Toride Kyodo General Hospital, Ibaraki, Japan.

Nihon Jinzo Gakkai Shi
|April 30, 2005
PubMed

Insights

Flow cytometry (FCM) analysis of mesothelial cells in peritoneal dialysis effluent reveals their condition impacts peritoneal function, independent of dialysis duration. Altered mesothelial cell morphology and quantity correlate with kidney function in patients undergoing peritoneal dialysis.

Area of Science:

  • Nephrology
  • Cell Biology
  • Biomedical Engineering

Context:

  • Peritoneal dialysis (PD) is a vital treatment for end-stage renal disease.
  • Assessing the condition of mesothelial cells in peritoneal dialysis effluent (PDE) is crucial for understanding peritoneal membrane health.
  • Current methods for evaluating mesothelial cells in PDE are limited.

Purpose:

  • To investigate the utility of flow cytometry (FCM) for analyzing mesothelial cells in PDE.
  • To explore the relationship between mesothelial cell characteristics, peritoneal dialysis duration, and peritoneal function.
  • To determine if mesothelial cell alterations correlate with the dialysate-to-plasma creatinine ratio (D/P creatinine).

Summary:

  • Flow cytometry was used to analyze mesothelial cells (identified by cytokeratin positivity) in the peritoneal dialysis effluent of 18 patients.
  • Forward scatter (FSC) of mesothelial cells positively correlated with D/P creatinine, while cytokeratin fluorescence intensity and cell percentage showed negative correlations.
  • No correlation was found between the duration of PD and mesothelial cell parameters (FSC, fluorescence intensity, or percentage).

Impact:

  • Mesothelial cell alterations in PDE, assessed by FCM, reflect changes in peritoneal function, not necessarily the duration of PD.
  • FCM analysis of mesothelial cells provides insights into the morphological and functional status of the peritoneum in PD patients.
  • This study suggests FCM is a valuable tool for monitoring peritoneal health and function during PD therapy.